← Leaderboards
Mathew Ryan Schnorenberg
University Of Chicago
$250,140
Attributed
$250,140
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51K · FY2017–21$100K$75K$50K$25K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$250,140 · 1
By mechanism
F30$250,140 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Benoit Roux$24,138,525
- Vladimir V Kalinichenko$15,264,853
- Rongxue Wu$2,820,525
- Cathryn R Nagler$8,943,535
- Jerry Allen Coyne$3,241,984
Others in their field
Other Emerging Leaders on “Antibodies”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$169,304,044
- Yunda Huang · Fred Hutchinson Cancer Center$73,421,550
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Hanjoon Ryu$28,519,898
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
Research focus
AntibodiesApoptosisAreaBaseB-Cell LymphomasBcl2 GeneBcl2l11 GeneBindingBiochemicalBiological AvailabilityBiophysicsBlood CirculationB-LymphocytesCancer CareCancer CellCancer TherapyCancer TypeCd19 AntigensCd19 GeneCell DeathCell LineCellsCell SurvivalAffinity
Grant awards (5)
A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles$51,036
F30 · FY2021 · CA · contact PI
A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles$50,520
F30 · FY2020 · CA · contact PI
A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles$50,016
F30 · FY2019 · CA · contact PI
A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles$49,524
F30 · FY2018 · CA · contact PI
A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles$49,044
F30 · FY2017 · CA · contact PI